Analystreport

Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.

Entasis Therapeutics Holdings Inc.  (ETTX) 
Last entasis therapeutics holdings inc. earnings: 11/14 07:30 am Check Earnings Report